MANCHESTER, Conn., Feb. 15, 2016 -- Lydall, Inc. (NYSE:LDL) today announced that Paul A. Marold, 54, has been appointed President, Lydall Performance Materials.
Mr. Marold will be joining Lydall from his position as the Chief Operating Officer of SONTARA®, a business division of Jacob Holm Group. SONTARA® is a global nonwovens business that produces products used in a wide variety of industrial and medical applications. Prior to joining SONTARA®, Mr. Marold held key customer-facing leadership positions at prominent filtration and nonwovens companies, such as CLARCOR, American Air Filter and Ahlstrom Oy, centered around strategic growth and innovation.
Commenting on Mr. Marold’s appointment, Dale G. Barnhart, President and Chief Executive Officer of the Company, said, “We are delighted to have Paul join Lydall’s executive leadership team. He brings extensive filtration industry experience with a successful track record in sales, marketing and operational excellence and a proven ability to drive profitable growth. He is an outstanding leader with a history of creating value for customers and shareholders in the very industries into which our Performance Materials segment serves.”
Mr. Marold holds a B.S. in Petroleum & Natural Gas Engineering from The Pennsylvania State University and completed his post-graduate studies at INSEAD in Fontainebleau, France. He is a member of the Executive Committee of the Board of Directors of the Association of the Nonwovens Fabrics Industry (INDA) and a former member of the Board of Directors of the National Air Filtration Association (NAFA).
Lydall, Inc. is a New York Stock Exchange listed company, headquartered in Manchester, Connecticut with global manufacturing operations producing specialty engineered products for the thermal/acoustical and filtration/separation markets. For more information, visit http://www.lydall.com. Lydall(R) is a registered trademark of Lydall, Inc. in the U.S. and other countries.
For further information: David D. Glenn Vice President, Corporate Development and Investor Relations Telephone 860-646-1233 Facsimile 860-646-4917 [email protected] www.lydall.com


FDA Approves Mitapivat for Anemia in Thalassemia Patients
BP Nears $10 Billion Castrol Stake Sale to Stonepeak
Eli Lilly and Novo Nordisk Battle for India’s Fast-Growing Obesity Drug Market
FTC Praises Instacart for Ending AI Pricing Tests After $60M Settlement
South Korean Court Clears Korea Zinc’s $7.4 Billion U.S. Smelter Project, Shares Surge
Sanofi to Acquire Dynavax in $2.2 Billion Deal to Strengthen Vaccines Portfolio
Waymo Plans Safety and Emergency Response Upgrades After San Francisco Robotaxi Disruptions
Hyundai Recalls Over 51,000 Vehicles in the U.S. Due to Fire Risk From Trailer Wiring Issue
Boeing Wins $2.04B U.S. Air Force Contract for B-52 Engine Replacement Program
DOJ Reaches Settlement With Blackstone’s LivCor Over Alleged Rent Price-Fixing
AstraZeneca’s LATIFY Phase III Trial of Ceralasertib Misses Primary Endpoint in Lung Cancer Study
John Carreyrou Sues Major AI Firms Over Alleged Copyrighted Book Use in AI Training
Nike Stock Jumps After Apple CEO Tim Cook Buys $2.9M Worth of Shares
Hanwha Signals Readiness to Build Nuclear-Powered Submarines at Philly Shipyard for U.S. Navy
Warner Bros Discovery Weighs Amended Paramount Skydance Bid as Netflix Takeover Battle Intensifies
Italy Fines Apple €98.6 Million Over App Store Dominance
Novo Nordisk Stock Surges After FDA Approves Wegovy Pill for Weight Loss 



